OtherClinical Investigations (Human)
Quantitative 3D assessment of 68Ga-DOTATOC PET/MRI with diffusion-weighted imaging to assess imaging markers for gastroendopancreatic neuroendocrine tumors: Preliminary results
Lisa C. Adams, Keno K. Bressem, Julia Brangsch, Carolin Reimann, Kristin J. Nowak, Winfried Brenner and Marcus R. Makowski
Journal of Nuclear Medicine December 2019, jnumed.119.234062; DOI: https://doi.org/10.2967/jnumed.119.234062
Lisa C. Adams
1 Department of Radiology and Nuclear Medicine, Charité, Germany;
Keno K. Bressem
1 Department of Radiology and Nuclear Medicine, Charité, Germany;
Julia Brangsch
1 Department of Radiology and Nuclear Medicine, Charité, Germany;
Carolin Reimann
1 Department of Radiology and Nuclear Medicine, Charité, Germany;
Kristin J. Nowak
1 Department of Radiology and Nuclear Medicine, Charité, Germany;
Winfried Brenner
2 Department of Nuclear Medicine, Charité, Germany
Marcus R. Makowski
1 Department of Radiology and Nuclear Medicine, Charité, Germany;

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
Quantitative 3D assessment of 68Ga-DOTATOC PET/MRI with diffusion-weighted imaging to assess imaging markers for gastroendopancreatic neuroendocrine tumors: Preliminary results
Lisa C. Adams, Keno K. Bressem, Julia Brangsch, Carolin Reimann, Kristin J. Nowak, Winfried Brenner, Marcus R. Makowski
Journal of Nuclear Medicine Dec 2019, jnumed.119.234062; DOI: 10.2967/jnumed.119.234062
Quantitative 3D assessment of 68Ga-DOTATOC PET/MRI with diffusion-weighted imaging to assess imaging markers for gastroendopancreatic neuroendocrine tumors: Preliminary results
Lisa C. Adams, Keno K. Bressem, Julia Brangsch, Carolin Reimann, Kristin J. Nowak, Winfried Brenner, Marcus R. Makowski
Journal of Nuclear Medicine Dec 2019, jnumed.119.234062; DOI: 10.2967/jnumed.119.234062
Jump to section
Related Articles
Cited By...
- No citing articles found.